The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...
There are multiple chapters near you. Select your preferred chapter.
A new study has found that women with systemic lupus erythematosus who have problems with memory and thinking (mild cognitive impairment, or MCI) exhibit morphological brain changes.
The 34th Annual Lupus Loop and Walk to End Lupus Now is part of the Lupus Foundation of America’s signature walk program. Hosted by the Pennsylvania Delaware Valley Region of the Lupus Foundation of ...
This isn’t just another conference, it’s a celebration of strength, community, and progress. We’re bringing together patients, families, doctors, researchers, and advocates who all share one powerful ...
The Lupus Foundation of America is dedicated to improving the quality of life for all people affected by lupus through programs of research, education, and advocacy.
Living with lupus can affect your social, emotional, and financial wellbeing. But there are things you can do to cope with lupus and get the support you need. When you’re living with lupus, managing ...
Run, Walk, Bike or Swim with the Lupus Foundation of America's endurance program, Racing to End Lupus,™ and Make Your Miles Matter in the fight to end lupus. Be a part of the Lupus Foundation of ...
This type I interferon receptor antagonist demonstrated early and sustained benefits for people with moderate to severe systemic lupus erythematosus. The U.S. Food and Drug Administration (FDA) has ...
Lupus can cause a lot of different skin problems, and there are many different kinds of medicines that can treat them. A special doctor called a dermatologist can help you find a treatment plan that ...
In a new study, researchers found people with clinically active systemic lupus erythematosus (SLE) disease on standard of care can attain or achieve low disease activity (LLDAS) and meet the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results